Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Photoreceptors and Visual Pathways

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Pediatric and Young Adult Choroidal and Ciliary Body Melanoma Genetic Study, A Survey by the European Ophthalmic Oncology Group.

Investigative ophthalmology & visual science·2024

Same author

Correlation between BAP1 Localization, Driver Mutations, and Patient Survival in Uveal Melanoma.

Cancers·2022

Same author

A Phase 1 study of ADI-PEG20 (pegargiminase) combined with cisplatin and pemetrexed in ASS1-negative metastatic uveal melanoma.

Pigment cell & melanoma research·2022

Same author

Long-term visual outcomes after ruthenium plaque brachytherapy for posterior choroidal melanoma.

Eye (London, England)·2022

Same author

Evaluation and management of a spontaneous corneal rupture secondary to pellucid marginal degeneration, using swept-source anterior segment optical coherence tomography.

Oxford medical case reports·2021

Same author

Iris extramedullary hematopoiesis in choroidal melanoma.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society·2021

Search research articles

Related Experiment Video

Updated: May 30, 2026

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Published on: December 2, 2022

Uveal melanoma.

Vasilios P Papastefanou¹, Victoria M L Cohen

¹Ocular Oncology Service, Moorfields Eye Hospital, London EC1V 2PD, UK.

Journal of Skin Cancer

|July 21, 2011

Summary

This summary is machine-generated.

Uveal melanoma, a fatal eye cancer, shows no survival improvement despite treatments. Metastasis is key, with genetics offering insights for new therapies and prognostication.

More Related Videos

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

Generation of a Liver Orthotopic Human Uveal Melanoma Xenograft Platform in Immunodeficient Mice

Generation of a Liver Orthotopic Human Uveal Melanoma Xenograft Platform in Immunodeficient Mice

Published on: November 6, 2019

Related Experiment Videos

Last Updated: May 30, 2026

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Published on: December 2, 2022

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

Generation of a Liver Orthotopic Human Uveal Melanoma Xenograft Platform in Immunodeficient Mice

Generation of a Liver Orthotopic Human Uveal Melanoma Xenograft Platform in Immunodeficient Mice

Published on: November 6, 2019

Area of Science:

Ophthalmology
Oncology
Genetics

Background:

Uveal melanoma is the most common primary intraocular malignancy in adults.
Despite advances in local ocular treatments, patient survival rates have stagnated for 30 years.
Metastasis significantly impacts prognosis and patient survival.

Purpose of the Study:

To discuss epidemiologic, pathogenetic, and clinical aspects of uveal melanoma.
To review current survival rates, predictive factors for metastasis, and screening algorithms.
To overview proposed and emerging treatments for uveal melanoma metastases.

Main Methods:

Review of epidemiologic, pathogenetic, and clinical data.
Analysis of current survival rates and metastatic potential predictors.
Overview of genetic and cytogenetic insights into tumor development.

Main Results:

No improvement in patient survival over three decades despite local treatments.
Metastasis is a critical factor influencing prognosis.
Genetic and cytogenetic research provides insights into high metastatic potential.

Conclusions:

Advances in genetics and cytogenetics are crucial for understanding uveal melanoma.
Biopsy may aid prognostication and identify therapeutic targets.
Further research into genetic mutations is needed for novel treatments.